NPRC/Institute
Center for Genetic Engineering and Biotechnology, Production Division, Havana, Cuba
Summary of Study
chimeric antigen, based on nucleocapsid of SARS-CoV-2 fused to the extracellular domain of human CD154 in HEK-293 cells
Year Published
2023
References
DOI: 10.1371/journal.pone.0288006
Contact Info
Mario Pablo Estrada: mario.pablo@cigb.edu.cu; Yamila Carpio: yamila.carpio@cigb.edu.cu
Keywords
SARS-CoV-2, chimeric antigen, vaccine, immune response, mice, primates
Coronavirus Investigated*
date entered
Study Type